NXTC FY 2018 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$35M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-12.04

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$5M

Stock-Based Comp.

$263,000

Balance Sheet

Total Assets

$148M

Total Liabilities

$195M

Stockholders' Equity

-$47M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$582,000	-188.1%
Operating Income	-$23M	-$16M	-49.2%
Net Income	-$23M	-$15M	-47.4%